GS Verde Group

DEAL: GS Verde Group – An AAB Group Company, were delighted to support Guilford Street Laboratories (GSL) with its third successful funding round, marking a significant growth milestone.

The investment will help support the next phase of the company’s development as it continues to advance its clinical programmes and expands its scientific and operational UK footprint.

The funding will enable Guilford Street Laboratories to grow its team, progress through clinical validation studies in key areas such as Parkinson’s disease and hypertrophic cardiomyopathy (HCM), product development acceleration and the generation of further clinical evidence.

🔗 Find out more about the deal here: https://www.gsverde.group/guilford-street-laboratories-completes-third-funding-round

UK employers are experiencing difficulty in offering competitive remuneration packages due to increases in employer National Enterprise Management Incentive (EMI) share option schemes were introduced a quarter of a century ago to support smaller, high growth companies in attracting and retaining key talent. It allows employees to acquire company shares in the future, allowing the to benefit from:

• Favourable income tax on gains
• Share price growth
• National Insurance Liabilities
In short, aligning shareholders and key employees.

In last year’s Autumn Budget, The Chancellor announced an expansion in eligibility for EMI, representing the most significant widening of the scope since its inception - allowing larger companies to participate in the scheme. This move has been welcomed by business owners, as it helps level the playing field by allowing more UK companies to offer employee share options as part of their remuneration packages.

Whilst both companies and employers need to satisfy certain conditions for the option to qualify for the EMI scheme and the associated tax benefits, the changes from April 2026 opens the scheme to larger companies that previously would not qualify.

🔗 Read more here, and find out how GS Verde Group can help your business navigate EMI scheme: https://www.gsverde.group/expansion-to-the-tax-efficient-emi-share-option-scheme-from-april-2026

DEAL: GS Verde Group were pleased to advise on the latest funding round deal for medical device company IQ Endoscopes.

The multi‑million‑pound follow-on investment into South Wales based IQ Endoscopes was led by BGF, alongside the Development Bank of Wales. GS Verde - An AAB Group Company advised IQ Endoscopes on the investment.

The latest round of funding will be used to support IQ Endoscopes’ early commercial rollout in selected UK centres, strengthen manufacturing and supply chain capability, build a robust commercial pipeline for future scale‑up in the UK and overseas and support further regulatory work and market validation in the US.

🔗 Find out more about the deal here: https://www.gsverde.group/iq-endoscopes-complete-funding-round